Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis

You'll see Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis.

Atelvia will be promoted as more convenient because it's taken AFTER breakfast...instead of 30 to 60 minutes BEFORE breakfast like the other oral bisphosphonates.

Atelvia is designed to reduce interference with calcium, iron, and other cations that decrease bisphosphonate absorption.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote